AMH Children's Dosing Companion 2026 - Book and Online Release

The July 2026 release of the AMH Children's Dosing Companion is now available as a book and online. This version includes content updates, dose changes and important safety information. Some that may be of interest include:

  • vanzacaftor with tezacaftor and deutivacaftor combination for cystic fibrosis
  • doses added for adrenaline (epinephrine) nasal spray for anaphylaxis
  • updated dosing advice for levetiracetam, metronidazole and tetracosactide
  • a safety reminder for benzylpenicillin and benzathine benzylpenicillin

Many small but important changes are made in every update of the CDC; these are outlined in the Summary of key changes. You should make checking this summary one of the first things you do with every new release.

AMH Online and Desktop App - July Content Updates

The AMH Online and Desktop App have been updated. Some of the recent changes that may be of interest include:

  • new drugs, eg ublituximab for MS, vanzacaftor with tezacaftor and deutivacaftor for cystic fibrosis
  • new indications, including semaglutide for metabolic dysfunction-associated steatohepatitis, finerenone for heart failure, and obinutuzumab for lupus nephritis
  • reviewed and updated information on the management of osteoarthritis
  • terminology updates, eg antiepileptics changed to antiseizure drugs
  • new formulations added, eg intranasal adrenaline, intranasal influenza vaccine
  • removed recently discontinued drugs, eg fluvastatin, and formulations, eg oxycodone suppositories.

See the Summary of key changes for all new and deleted drugs.

If you’re new to AMH, make sure you watch our videos.

AMH Aged Care Companion Online – May 2026 Release

The May 2026 release of the AMH Aged Care Companion is now available as a book and online. The new version includes content updates and a number of changes, including:

  • updated topics including asthma, coronary heart disease, depression, dyslipidaemia, fall prevention, heart failure, nausea and vomiting, osteoporosis
  • terminology updates, eg aldosterone antagonists changed to mineralocorticoid receptor antagonists, hormone replacement therapy to menopausal hormone therapy.

Many changes are made in every update of the ACC; these are outlined in the Summary of key changes. You should make checking this summary one of the first things you do with every new release.

Beware - buying electronic AMH products from other sources

Electronic versions of all AMH products are ONLY available for purchase from the AMH website. Any other website advertising the sale of AMH products may contain malicious software that may harm the integrity of your computer.

Likewise, any unauthorised email offer on these products could be spam. If you are unsure of its content, please delete the email and report the incident to us via sales@amh.net.au

To buy AMH print products, please go to the support page of the AMH website and select AMH Stockists found under the heading Where to buy AMH products.